Home
Magna Scientia Advanced Biology and Pharmacy
Peer-Reviewed • ISSN: 2582-8363 • Fast-Track Publishing • Impact Factor 8.6 • Low Publication Charges • Crossref DOI Linking

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September - October 2026 (Volume 19, Issue 1) Submit manuscript

Determination of inhibitory activities of the constituents of Curcuma longa (l) against Streptococcus pneumoniae by molecular docking simulation

Breadcrumb

  • Home
  • Determination of inhibitory activities of the constituents of Curcuma longa (l) against Streptococcus pneumoniae by molecular docking simulation

Chigozie Celestina Ezeagha 1, Amarachi Nnaoma-Gabriel 1, joseph Orjiakor 1, Juliet Orakwe 1, Blessing Ejiro Otarigho 2 and Emmanuel Chuks Oranu 1, *

1 Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmaceutical Sciences, Chukwuemeka Odumegwu Ojukwu University, Igbariam Anambra State.
2 Department of Pharmacology and Therapeutics, Faculty of Basic Medical sciences, Delta State University, Abraka, Delta State.
Research Article
Magna Scientia Advanced Biology and Pharmacy, 2025, 16(01), 016-027
Article DOI: 10.30574/msabp.2025.16.1.0061
DOI url: https://doi.org/10.30574/msabp.2025.16.1.0061
Received on 05 August 2025; revised on 11 September 2025; accepted on 13 September 2025
Streptococcus pneumoniae is a major cause of community-acquired pneumonia (CAP), particularly affecting children, the elderly, and immunocompromised individuals. Its polysaccharide capsule helps it evade immune defenses, leading to lung infections characterized by fever, cough, and respiratory distress. The bacteria spread through respiratory droplets, posing a significant public health risk. Although pneumococcal vaccines have reduced the incidence of pneumonia, non-vaccine serotypes and antibiotic resistance continue to challenge prevention and treatment efforts. This study aimed to utilize computational methods and tools to predict, analyze, and understand the potential anti-pneumonial effects of phytochemical compounds derived from Curcuma longa on the bacterium responsible for causing pneumonia. To accomplish this, a target protein of Streptococcus pneumoniae was selected from the Protein Data Bank for further analysis. The receptor (4IVV) was prepared using Chimera-1.10.1, PyMOL-2.3.0, and Autodock Tools-1.5.6, with the same preparation process applied to the reference ligand (EDO). Phytochemicals were selected from Drug Bank and PubChem database, then screened using Data Warrior based on Lipinski's Rule of Five and toxicity criteria. The screened phytochemicals were subsequently extracted and prepared with Autodock Tools-1.5.6. The docking protocol was validated, followed by molecular docking using autodock-vina. The docking results were then analyzed and visualized using PyMOL-2.3.0. After completing the procedures, the reference ligand exhibited a mean binding energy of -2.5 Kcal/mol. In comparison, the 105 phytoconstituents, including the top 10 candidates, showed lower binding energies, ranging from -8.1 Kcal/mol to -6.5 Kcal/mol, indicating a stronger binding affinity than the reference ligand.
Pneumonia; Curcuma Longa; Streptococcus Pneumoniae; Community-Acquired Pneumonia (CAP); Phytochemicals; Molecular Docking; Binding Energies; Reference Ligand
https://msabp.magnascientiapub.com/sites/default/files/fulltext_pdf/MSABP-2025-…

Preview Article PDF

Chigozie Celestina Ezeagha, Amarachi Nnaoma-Gabriel, joseph Orjiakor, Juliet Orakwe, Blessing Ejiro Otarigho and Emmanuel Chuks Oranu. Determination of inhibitory activities of the constituents of Curcuma longa (l) against Streptococcus pneumoniae by molecular docking simulation. Magna Scientia Advanced Biology and Pharmacy, 2025, 16(1), 016-027. Article DOI: https://doi.org/10.30574/msabp.2025.16.1.0061

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 Magna Scientia Advanced Biology and Pharmacy - All rights reserved

Developed & Designed by VS Infosolution